Johnson & Johnson (JNJ.N) is voluntarily recalling five Neutrogena and Aveeno brand aerosol sunscreen products after detecting a cancer-causing chemical in some samples.
The New Jersey-based company said on Wednesday that consumers should stop using the products and discard them after internal testing identified low levels of benzene in some samples.
The only sunscreen products impacted are aerosol products, specifically:
- NEUTROGENA® Beach Defense® aerosol sunscreen,
- NEUTROGENA® Cool Dry Sport aerosol sunscreen,
- NEUTROGENA® Invisible Daily™ defense aerosol sunscreen,
- NEUTROGENA® Ultra Sheer® aerosol sunscreen,
- AVEENO® Protect + Refresh aerosol sunscreen.
[Here’s the complete USAerosolSunscreenProductList]
J&J is also notifying distributors and retailers to stop selling the products and arranging for their return “out of an abundance of caution”.
Benzene is classified as a human carcinogen, a substance that could potentially cause cancer depending on the level and extent of exposure.
J&J said that benzene is not an ingredient in its sunscreen products and it is investigating the cause of the contamination.
“Daily exposure to benzene in these aerosol sunscreen products at the levels detected in our testing would not be expected to cause adverse health consequences,” the company said.
The recalled aerosol sunscreens are Neutrogena Beach Defense, Neutrogena Cool Dry Sport, Neutrogena Invisible Daily defense, Neutrogena Ultra Sheer and Aveeno Protect + Refresh.
Consumers should contact their physician or healthcare provider if they have any concerns, questions or have experienced any problems related to using these products.
The recall is another blow for J&J, one of the world’s largest producers of consumer health products. The company already faces billions of dollars of potential court losses and settlements from damages claims related to its baby powder, vaginal mesh implants and opioid painkillers.
J&J’s COVID-19 vaccine rollout has also been hampered by production problems and the shot has been linked to two very rare side effects: Guillain-Barré Syndrome and a potentially life threatening blood clotting condition.
U.S. regulators have said that the vaccine’s benefits outweigh the risks.
Reporting by Sabahatjahan Contractor in Bengaluru Editing by Subhranshu Sahu, Carmel Crimmins and David Goodman
Republished with permission[/vc_message]
Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components
